P20. TACI-signalling in multiple myeloma ?From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

Jér?me Moreaux; Dirk Hose; John De Vos; Jean-Fran?ois Rossi; Karène Mahtouk; Thierry Rème; Thomas M?hler; Marion Moos; Eric Jourdan; Friedrich W.Cremer; Hartmut Goldschmidt; Bernard Klein

首页> 外文期刊>European Journal of Cancer Supplements >P20. TACI-signalling in multiple myeloma ?From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

【24h】

P20. TACI-signalling in multiple myeloma ?From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

机译：P20。多发性骨髓瘤的TACI信号传递-从通过基因表达分析和功能测试鉴定为潜在治疗靶点到临床试验

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第6期|共1页
作者
Jér?me Moreaux; Dirk Hose; John De Vos; Jean-Fran?ois Rossi; Karène Mahtouk; Thierry Rème; Thomas M?hler; Marion Moos; Eric Jourdan; Friedrich W.Cremer; Hartmut Goldschmidt; Bernard Klein;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P43. ErbB-signalling in multiple myeloma ?From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials [J] . Karène Mahtouk, Dirk Hose, John De Vos, European Journal of Cancer Supplements . 2006,第6期

机译：P43。多发性骨髓瘤的ErbB信号转导-从通过基因表达分析和功能测试鉴定为潜在治疗靶点到临床试验
2. Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR) [J] . Willenbacher Wolfgang, Thangavadivel Shanmugapriya, Greil Richard, Leukemia and lymphoma . 2016,第10期

机译：低Beclin-1表达预测多发性骨髓瘤用免疫调节药物治疗的患者的总生存期提高，并将自噬抑制确定为有希望的潜在可药物治疗的新治疗靶标：奥地利骨髓瘤注册机构（AMR）的分析
3. Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma (Journal of Clinical Oncology (2009) 27 (4197-4203)) [J] . Rao, Noauthornameavailable Journal of Clinical Oncology . 2012,第5期

机译：肿瘤生物学的基因表达谱提供了一种新的预后方法，并可能指导多发性骨髓瘤的治疗靶标选择（Journal of Clinical Oncology（2009）27（4197-4203））
4. TREATING MULTIPLE MYELOMA IN A CLINICAL TRIAL [C] . Annual Conference of the Veterinary Cancer Society. . 2017

机译：在临床试验中治疗多发性骨髓瘤
5. The survival role and the potential therapeutic targeting of MET in multiple myeloma. [D] . Phillip, Cornel. 2009

机译：MET在多发性骨髓瘤中的生存作用和潜在的治疗靶向性。
6. Neoplasia: An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma [O] . Wei Xiong, Xiaosong Wu, Sarah Starnes, -1

机译：瘤形成：TP53丢失的临床和生物学意义分析和多发性骨髓瘤中潜在的新型TP53转录靶标的鉴定
7. P20. TACI-signalling in multiple myeloma – From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials [O] . Moreaux Jérôme, Hose Dirk, De Vos John, 2006

机译：P20。多发性骨髓瘤的TACI信号转导–从通过基因表达分析和功能测试鉴定为潜在治疗靶点到临床试验

P20. TACI-signalling in multiple myeloma ?From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

著录项

相似文献

相关主题

期刊订阅